BriaCell Therapeutics Corp. (TSX:BCT)
Canada
· Delayed Price · Currency is CAD 4.690
+0.150 (3.30%)
Jun 6, 2025, 1:56 PM EDT
BriaCell Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is August - July.
Millions USD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jan '25 Jan 31, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Jul '20 Jul 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 5.01 | 0.86 | 21.25 | 41.04 | 57.27 | 0.02 | Upgrade
|
| Cash & Short-Term Investments | 5.01 | 0.86 | 21.25 | 41.04 | 57.27 | 0.02 | Upgrade
|
| Cash Growth | -19.71% | -95.94% | -48.22% | -28.34% | 269412.38% | -86.47% | Upgrade
|
| Other Receivables | 2.15 | 0.74 | - | 0.02 | 0.01 | 0.02 | Upgrade
|
| Receivables | 2.15 | 0.74 | - | 0.02 | 0.01 | 0.02 | Upgrade
|
| Prepaid Expenses | - | 2.06 | 5.7 | 1.28 | 0.52 | 0.22 | Upgrade
|
| Total Current Assets | 7.16 | 3.65 | 26.95 | 42.35 | 57.8 | 0.26 | Upgrade
|
| Property, Plant & Equipment | 0.34 | 0.39 | - | - | - | - | Upgrade
|
| Long-Term Investments | 0.45 | 0.42 | 0 | 0 | 0 | 0 | Upgrade
|
| Other Intangible Assets | 0.19 | 0.2 | 0.22 | 0.23 | 0.25 | 0.26 | Upgrade
|
| Other Long-Term Assets | 1.21 | 1.21 | - | - | - | - | Upgrade
|
| Total Assets | 9.36 | 5.87 | 27.16 | 42.58 | 58.04 | 0.52 | Upgrade
|
| Accounts Payable | 5 | 7.17 | 1.12 | 0.46 | 0.21 | 3.17 | Upgrade
|
| Accrued Expenses | 0.23 | 0.29 | 0.68 | 0.48 | 0.34 | 0.54 | Upgrade
|
| Short-Term Debt | - | - | - | - | - | 0.25 | Upgrade
|
| Total Current Liabilities | 5.23 | 7.46 | 1.8 | 0.94 | 0.56 | 3.96 | Upgrade
|
| Long-Term Debt | - | - | - | - | 0.03 | 0.16 | Upgrade
|
| Other Long-Term Liabilities | 0.91 | 1.1 | 29.14 | 31.31 | 29.79 | - | Upgrade
|
| Total Liabilities | 6.14 | 8.56 | 30.94 | 32.25 | 30.37 | 4.12 | Upgrade
|
| Common Stock | 85.45 | 72.17 | 69.59 | 65.59 | 54.77 | 12.26 | Upgrade
|
| Additional Paid-In Capital | - | - | - | - | 2.18 | - | Upgrade
|
| Retained Earnings | -97.54 | -85.44 | -80.65 | -60.35 | -29.14 | -18.17 | Upgrade
|
| Comprehensive Income & Other | 15.69 | 10.89 | 7.28 | 5.09 | -0.14 | 2.31 | Upgrade
|
| Total Common Equity | 3.6 | -2.38 | -3.78 | 10.33 | 27.67 | -3.6 | Upgrade
|
| Minority Interest | -0.38 | -0.3 | - | - | - | - | Upgrade
|
| Shareholders' Equity | 3.23 | -2.68 | -3.78 | 10.33 | 27.67 | -3.6 | Upgrade
|
| Total Liabilities & Equity | 9.36 | 5.87 | 27.16 | 42.58 | 58.04 | 0.52 | Upgrade
|
| Total Debt | - | - | - | - | 0.03 | 0.41 | Upgrade
|
| Net Cash (Debt) | 5.01 | 0.86 | 21.25 | 41.04 | 57.24 | -0.38 | Upgrade
|
| Net Cash Growth | -19.71% | -95.94% | -48.22% | -28.30% | - | - | Upgrade
|
| Net Cash Per Share | 2.99 | 0.79 | 20.41 | 39.73 | 189.98 | -8.08 | Upgrade
|
| Filing Date Shares Outstanding | 3.71 | 1.22 | 1.07 | 1.03 | 1.02 | 0.05 | Upgrade
|
| Total Common Shares Outstanding | 2.95 | 1.22 | 1.07 | 1.03 | 1.02 | 0.05 | Upgrade
|
| Working Capital | 1.93 | -3.81 | 25.15 | 41.41 | 57.24 | -3.7 | Upgrade
|
| Book Value Per Share | 1.22 | -1.95 | -3.55 | 9.98 | 27.18 | -74.74 | Upgrade
|
| Tangible Book Value | 3.41 | -2.58 | -3.99 | 10.1 | 27.43 | -3.86 | Upgrade
|
| Tangible Book Value Per Share | 1.16 | -2.12 | -3.75 | 9.76 | 26.94 | -80.16 | Upgrade
|
| Machinery | - | 0.46 | - | - | - | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.